BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7228848)

  • 21. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical significance of cholesterol excretion in the urine].
    Jüngst D; Osterholzer M; Lazik E; Karl HJ
    Acta Med Austriaca Suppl; 1979; 6():406-9. PubMed ID: 299242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possibilities for an extended classification of bladder cancer.
    Wahren B; Nilsson B; Esposti PL; Edsmyr F; Holmberg V
    Urol Res; 1984; 12(4):195-7. PubMed ID: 6495445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls.
    Guinan P; Ablin RJ; Sadoughi N; Bush IM
    J Surg Oncol; 1974; 6(2):127-31. PubMed ID: 4822898
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary carcinoembryonic like antigen levels in patients with urinary tract reconstruction using bowels.
    Oshiumi Y; Yagi H; Nishitani H; Nakayama C; Kamoi I; Matsuura K; Momose S
    Radioisotopes; 1978 Aug; 27(8):456-9. PubMed ID: 734164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical value of tumour-associated antigens.
    Neville AM
    J Clin Pathol Suppl (R Coll Pathol); 1974; 7():119-26. PubMed ID: 4208587
    [No Abstract]   [Full Text] [Related]  

  • 27. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urine determination of CEA, CA50 and TPA as tumor markers in bladder neoplasms].
    Morote J; López-Pacios MA; Encabo G; de Torres JA
    Med Clin (Barc); 1990 Jun; 95(3):119. PubMed ID: 2123505
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening tests for detection of bladder cancer.
    Betkerur V; Rao R; Hlaing V; Rhee H; Baumgartner G; Guinan P
    Urology; 1980 Jul; 16(1):16-9. PubMed ID: 7395005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CEA determination in urogenital tract neoplasms].
    Hering H; Weidner W; Hering F
    Med Lab (Stuttg); 1976 Sep; 29(9):193-8. PubMed ID: 979885
    [No Abstract]   [Full Text] [Related]  

  • 31. [Urinary carcinoembryonic antigen in patients with urothelial tumors. Correlations with the stage of the disease and the modal chromosome number].
    Lazăr C; Pop T; Dumitrache D; Mamulea O
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1978; 27(5):379-85. PubMed ID: 740964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of carcinoembryonic antigen in urine and in gastric secretions].
    Menduni P; Di Sciascio G; Lisanti A; Caracino A
    Minerva Med; 1983 Nov; 74(44):2671-5. PubMed ID: 6657117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
    Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
    Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
    Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
    Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III.
    Persijn JP; Korsten CB; Batterman JJ; Tierie AH; Renaud J
    J Clin Chem Clin Biochem; 1976 Aug; 14(8):395-9. PubMed ID: 965893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?
    Mahnert B; Tauber S; Kriegmair M; Schmitt UM; Hasholzner U; Reiter W; Hofmann K; Schmeller N; Stieber P
    Anticancer Res; 1999; 19(4A):2615-9. PubMed ID: 10470204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcino-embryonic antigen activity in urine of patients with bladder carcinoma. Clinical evaluation of carcino-embryonic antigen. II.
    Korsten CB; Persijn JP; Renaud J; Houtzager-Boelens CA
    J Clin Chem Clin Biochem; 1976 Aug; 14(8):389-93. PubMed ID: 965892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma.
    Neville AM; Nery R; Hall RR; Turberville C; Laurence DJ
    Br J Cancer Suppl; 1973 Aug; 1():198-207. PubMed ID: 4216361
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: Heavy smoking and C.E.A.
    Lancet; 1973 Dec; 2(7840):1249. PubMed ID: 4128571
    [No Abstract]   [Full Text] [Related]  

  • 40. Proteinuria after intravesical chemotherapy.
    Cooper EH; Yu H; Glashan RW; Robinson MR; Newling DW
    Prog Clin Biol Res; 1985; 185B():167-71. PubMed ID: 3929270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.